- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lustrombopag is an oral thrombopoietin receptor agonist that increases platelet count by stimulating megakaryocyte proliferation and differenti...
Dimethyl phosphate tablets (Astomin) are a central cough suppressant that mainly acts on the medullary cough center, exerting an antitussive ef...
The usage and dosage of Astomin tablets should be adjusted according to the indications, and special populations should pay attention to differ...
Aprocitentan is a dual endothelin receptor antagonist primarily used to treat refractory hypertension. Its target population, limitations, and ...
As an endothelin receptor antagonist, the side effects of Aprocitentan mainly involve systemic reactions such as fluid retention, liver dysfunc...
Tofacitinib, as a JAK inhibitor, needs to be adjusted according to indications in terms of usage and dosage. Special attention should be paid t...
Tofacitinib is an oral JAK inhibitor mainly used to treat autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis, exerting im...
Regorafenib is a multi kinase inhibitor suitable for the treatment of malignant tumors such as metastatic colorectal cancer and hepatocellular ...
Regorafenib, as a multi kinase inhibitor, commonly has side effects such as skin reactions, hypertension, fatigue, etc. Most of them can be rel...
Olaparib is a PARP inhibitor, which is suitable for the treatment of BRCA mutation related ovarian cancer, breast cancer and other malignant tu...
